BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loukovaara S, Sahanne S, Takala A, Haukka J. Statin use and vitreoretinal surgery: Findings from a Finnish population-based cohort study. Acta Ophthalmol 2018;96:442-51. [PMID: 29338115 DOI: 10.1111/aos.13641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ilhan C, Citirik M, Teke MY. Vitreoretinal Surgery amid Coronavirus Disease 2019 Pandemic Restrictions. J Curr Ophthalmol 2021;33:310-6. [PMID: 34765820 DOI: 10.4103/joco.joco_89_21] [Reference Citation Analysis]
2 Loukovaara S, Haukka J. Repair of primary RRD - comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantation. Clin Ophthalmol 2018;12:1449-57. [PMID: 30147297 DOI: 10.2147/OPTH.S171451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
3 Virtanen A, Haukka J, Harju M, Loukovaara S. Statin use and the reoperation rates in glaucoma filtration surgery - population-based cohort study. Acta Ophthalmol 2021. [PMID: 33755323 DOI: 10.1111/aos.14860] [Reference Citation Analysis]
4 Pescina S, Sonvico F, Clementino A, Padula C, Santi P, Nicoli S. Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye. Pharmaceutics 2021;13:855. [PMID: 34207544 DOI: 10.3390/pharmaceutics13060855] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Vail D, Callaway NF, Ludwig CA, Saroj N, Moshfeghi DM. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes. American Journal of Ophthalmology 2019;207:378-84. [DOI: 10.1016/j.ajo.2019.05.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Mysore Y, Del Amo EM, Loukovaara S, Hagström M, Urtti A, Kauppinen A. Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous. Sci Rep 2021;11:980. [PMID: 33441813 DOI: 10.1038/s41598-020-80127-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dai Y, Dai C, Sun T. Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review. Int Ophthalmol 2020;40:1587-601. [PMID: 32103371 DOI: 10.1007/s10792-020-01325-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rodríguez ML, Pérez S, Mena-Mollá S, Desco MC, Ortega ÁL. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.Oxid Med Cell Longev. 2019;2019:4940825. [PMID: 31814880 DOI: 10.1155/2019/4940825] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
9 Danni R, Taipale C, Holmström EJ, Ilveskoski L, Tuuminen R. Systemic use of calcium channel blockers associated with less increase in central retinal thickness after uncomplicated cataract surgery. Acta Ophthalmol 2019;97:178-84. [PMID: 30187630 DOI: 10.1111/aos.13911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]